Ziosoft to Feature ECV-CT and New Revoras Enabled ECV-CMR Analytics at Annual American College of Cardiology Conference
NEWARK, Calif., March 2, 2023 /PRNewswire-PRWeb/ -- Ziosoft, a pioneer in 3D/4D AI medical visualization, will feature extracellular volume fraction (ECV) computed tomography (CT) and Revoras-enabled ECV cardiac magnetic resonance (CMR) analytical capabilities at the annual American College of Cardiology (ACC) conference being held March 4-6, 2023 in New Orleans. The Revoras software is the company's most recent development, offering a scalable, enterprise platform.
- The Revoras software is the company's most recent development, offering a scalable, enterprise platform.
- "Ziosoft's software enables accurate image intelligence along with a superb, stable algorithm," said Rajeev Taitriya, vice president of marketing and business development for Ziosoft.
- It provides protocols such as calcium scoring, coronary and transcatheter aortic valve replacement (TAVR) analysis.
- It is a noninvasive method to quantity myocardial interstitial volume in a range of heart diseases such as Amyloids.